GeneGlobe ID: YHS-101Z | Cat. No.: | QIAseq Targeted cfDNA Ultra Panels

QIAseq Targeted cfDNA Ultra Human Actionable Solid Tumor Panel

Kit containing ALL reagents (except indexes) for targeted DNA sequencing

Select a variant to see the price

Product Specification

Target List

Exons
NRAS, PDGFRA, PIK3CA, PMS2CL
Exons & Hotspots
PMS2
Hotspots
ABL1, AKT1, ALB, ALK, APOB, AR, ARAF, ARID1A, ARID2, ATM, AXIN1, BRAF, CCND1, CCNE1, CDH1, CDKN2A, CHEK2, CREBBP, CSF1R, CSF3R, CTNNB1, DPYD, ERBB3, ERCC1, ERCC2, ESR1, EZH2, FANCM, FBXW7, FGFR2, FGFR3, FLT3, FOXA1, FOXL2, GNAS, HRAS, IDH1, IDH2, JAK1, JAK2, KDM6A, KEAP1, KMT2D, MAP2K1, MAPK1, MED12, MPL, MSH6, MYC, MYD88, NF2, NFE2L2, NOTCH1, NTRK1, PIK3R1, POLE, PPP2R1A, PTPN11, RB1, RET, RIT1, RNF43, ROS1, RRAS, RRAS2, RUNX1, SF3B1, SMAD4, SPOP, SRSF2, STAT3, STK11, TCF7L2, TGFBR2, TSC2, U2AF1, UGT1A1
Promoter
TERT
Promoter & Hotspots
APC, MLH1, MSH2, PTEN
Whole Coding
BRCA1, BRCA2, EGFR, ERBB2, KRAS, MET, TP53
Bladder Cancers
AKT1, ARID1A, ATM, BRAF, CCND1, CCNE1, CDKN2A, CTNNB1, ERBB2, ERBB3, ERCC2, FGFR2, FGFR3, HRAS, JAK2, KDM6A, KRAS, MPL, PIK3CA, PTEN, RB1, TP53, U2AF1
Brain Cancers
ALK, APC, BRAF, BRCA2, CDKN2A, CHEK2, CREBBP, CTNNB1, EGFR, ERBB2, FGFR3, IDH1, IDH2, KIT, KRAS, MET, MLH1, MSH2, MYC, NF2, NOTCH1, NRAS, PDGFRA, PIK3CA, PMS2, PMS2CL, PTEN, PTPN11, RB1, STK11, TERT, TP53
Breast Cancers
AKT1, AR, ARAF, ATM, BRCA1, BRCA2, CCND1, CDH1, CHEK2, EGFR, ERBB2, ERBB3, ESR1, FBXW7, FGFR2, FLT3, JAK2, KIT, KRAS, MET, MLH1, MPL, MSH2, MSH6, MYC, PDGFRA, PIK3CA, PMS2, PMS2CL, PPP2R1A, PTEN, RUNX1, SF3B1, STK11, TP53, U2AF1
Cervical Cancers
ARAF, MAPK1, MPL
Colorectal Cancers
AKT1, APC, ARID1A, ATM, BRAF, BRCA1, BRCA2, CDKN2A, CHEK2, CSF1R, CTNNB1, DPYD, EGFR, ERBB2, ERBB3, ERCC1, ESR1, FBXW7, FGFR3, FLT3, GNAS, HRAS, JAK2, KIT, KRAS, MAP2K1, MET, MLH1, MPL, MSH2, MSH6, MYC, NRAS, PDGFRA, PIK3CA, PMS2, PMS2CL, POLE, PTEN, RET, RNF43, SMAD4, SRSF2, STK11, TCF7L2, TGFBR2, TP53, UGT1A1
Gastric Cancers
APC, ARAF, ARID1A, BRAF, CDH1, CDKN2A, CTNNB1, ERBB2, ERBB3, FBXW7, GNAS, JAK2, KIT, KMT2D, KRAS, MET, MPL, MYC, PDGFRA, PIK3CA, PTEN, RNF43, SMAD4, SRSF2, TP53
Liver Cancers
ALB, APC, APOB, ARID1A, ARID2, AXIN1, BRAF, CCND1, CDKN2A, CREBBP, CTNNB1, IDH1, IDH2, JAK1, JAK2, KEAP1, KRAS, MYC, NFE2L2, NRAS, PIK3CA, RB1, RIT1, TP53, TSC2
Lung Cancers
ABL1, AKT1, ALK, ARAF, ATM, BRAF, BRCA1, BRCA2, CCND1, CDKN2A, CHEK2, CSF3R, CTNNB1, EGFR, ERBB2, FGFR3, FLT3, HRAS, IDH1, JAK2, KIT, KRAS, MAP2K1, MET, MLH1, MPL, MSH2, MSH6, MYC, NF2, NRAS, NTRK1, PDGFRA, PIK3CA, PMS2, PMS2CL, PTEN, RB1, RET, ROS1, RRAS, STK11, TP53, TSC2, U2AF1
Lymphomas
ARID1A, ATM, BRAF, CCND1, CDKN2A, CHEK2, CREBBP, EZH2, GNAS, IDH1, IDH2, JAK1, KMT2D, MAP2K1, MYC, MYD88, NOTCH1, NRAS, PIK3CA, SF3B1, STAT3, TP53
Melanomas
ARID2, ATM, BRAF, BRCA1, BRCA2, CCND1, CDKN2A, CHEK2, CREBBP, CTNNB1, EGFR, EZH2, HRAS, IDH1, KIT, KRAS, MAP2K1, MLH1, MSH2, MSH6, NRAS, PDGFRA, PIK3CA, PTEN, RB1, TP53
Ovarian Cancers
AKT1, ARID1A, ATM, BRAF, BRCA1, BRCA2, CCND1, CCNE1, CDH1, CDKN2A, CHEK2, CTNNB1, ERBB2, ERBB3, ERCC1, FANCM, FBXW7, FGFR2, FGFR3, FOXL2, KIT, KRAS, MLH1, MPL, MSH2, MSH6, MYC, PDGFRA, PIK3CA, PIK3R1, PMS2, PMS2CL, POLE, PPP2R1A, PTEN, RB1, RRAS2, STK11, TP53
Pancreatic Cancers
APC, ARID1A, ATM, BRAF, BRCA1, BRCA2, CDKN2A, CTNNB1, ERBB2, ERBB3, FBXW7, GNAS, JAK2, KDM6A, KRAS, MET, MLH1, MSH2, MSH6, MYC, NRAS, PIK3CA, PMS2, PMS2CL, POLE, PTEN, RNF43, SMAD4, STK11, TCF7L2, TP53, U2AF1
Prostate Cancers
AKT1, APC, AR, ARAF, ATM, BRAF, BRCA1, BRCA2, CHEK2, CTNNB1, FOXA1, HRAS, IDH1, JAK2, KDM6A, KMT2D, KRAS, MED12, MLH1, MPL, MSH2, MSH6, MYC, PIK3CA, PIK3R1, PMS2, PMS2CL, PTEN, RB1, SPOP, TP53, U2AF1

Product Resources

Product Specification Sheet
File Size: 74.29 KBLanguage: English

Resources

Kit Handbooks (2)
For ultrasensitive targeted next-generation sequencing (NGS) of cfDNA for Illumina NGS systems
For ultrasensitive targeted next-generation sequencing (NGS) of cfDNA for Illumina NGS systems
Safety Data Sheets (1)
Certificates of Analysis (1)
Introducing the QIAseq Targeted cfDNA Ultra Human Actionable Solid Tumor Panel, a cutting-edge addition to our QIAseq Targeted cfDNA Ultra Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Targeted cfDNA Ultra Human Actionable Solid Tumor Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Targeted cfDNA Ultra Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Targeted cfDNA Ultra Human Actionable Solid Tumor Panel and elevate your work to new heights.